Novo Nordisk Stock Options Expiring on 15th of January 2027
| NVO Stock | USD 111.94 2.75 2.52% |
Novo Nordisk's latest option contracts expiring on 2027-01-15 are carrying combined implied volatility of 0.36 with a put-to-call open interest ratio of 0.66 over 53 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on 2027-01-15. The total put volume is at 159, with calls trading at the volume of 159. This yields a 1.51 put-to-call volume ratio.
Open Interest Against 2027-01-15 Option Contracts
2027-01-15
The chart above shows Novo Nordisk's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Novo Nordisk's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Novo Nordisk's option, there is no secondary market available for investors to trade.
Novo Nordisk Maximum Pain Price across 2027-01-15 Option Contracts
Max pain occurs when Novo Nordisk's market makers reach a net positive position across all Novo Nordisk's options at a strike price where option holders stand to lose the most money. By contrast, Novo Nordisk's option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Nordisk AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Please note that buying 'in-the-money' options on Novo Nordisk lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Novo Nordisk's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Novo Nordisk contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Novo Stock moves the wrong way.
Novo Nordisk AS In The Money Call Balance
When Novo Nordisk's strike price is surpassing the current stock price, the option contract against Novo Nordisk AS stock is said to be in the money. When it comes to buying Novo Nordisk's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Novo Nordisk AS are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Novo Current Options Market Mood
Novo Nordisk's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Novo Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Novo Nordisk's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Novo Nordisk's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Novo contract
Base on the Rule 16, the options market is currently suggesting that Novo Nordisk AS will have an average daily up or down price movement of about 0.0225% per day over the life of the 2027-01-15 option contract. With Novo Nordisk trading at USD 111.94, that is roughly USD 0.0252. If you think that the market is fully incorporating Novo Nordisk's daily price movement you should consider buying Novo Nordisk AS options at the current volatility level of 0.36%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Novo |
Novo Nordisk Option Chain
When Novo Nordisk's strike price is surpassing the current stock price, the option contract against Novo Nordisk AS stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2024-12-132024-12-202024-12-272025-01-032025-01-102025-01-172025-01-242025-02-212025-03-212025-04-172025-06-202025-09-192026-01-162027-01-15
Novo Nordisk's option chain is a display of a range of information that helps investors for ways to trade options on Novo. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Novo. It also shows strike prices and maturity days for a Novo Nordisk against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | NVO Option Call 15-01-2027 55 | 63 | 2027-01-15 | 59.0 - 63.5 | 61.23 | In |
Call | NVO Option Call 15-01-2027 60 | 25 | 2027-01-15 | 55.0 - 59.5 | 56.61 | In |
Call | NVO Option Call 15-01-2027 65 | 21 | 2027-01-15 | 51.85 - 55.5 | 51.55 | In |
Call | NVO Option Call 15-01-2027 70 | 24 | 2027-01-15 | 48.2 - 52.0 | 48.35 | In |
Call | NVO Option Call 15-01-2027 75 | 6 | 2027-01-15 | 44.5 - 48.5 | 44.77 | In |
Call | NVO Option Call 15-01-2027 80 | 19 | 2027-01-15 | 41.15 - 45.0 | 38.95 | In |
Call | NVO Option Call 15-01-2027 85 | 4 | 2027-01-15 | 37.85 - 41.5 | 38.7 | In |
Call | NVO Option Call 15-01-2027 90 | 32 | 2027-01-15 | 34.9 - 38.5 | 34.5 | In |
Call | NVO Option Call 15-01-2027 95 | 41 | 2027-01-15 | 31.1 - 35.25 | 31.35 | In |
Call | NVO Option Call 15-01-2027 100 | 292 | 2027-01-15 | 28.6 - 33.0 | 30.5 | In |
Call | NVO Option Call 15-01-2027 105 | 64 | 2027-01-15 | 26.9 - 30.5 | 27.0 | In |
Call | NVO Option Call 15-01-2027 110 | 325 | 2027-01-15 | 24.6 - 28.0 | 24.88 | In |
Call | NVO Option Call 15-01-2027 115 | 331 | 2027-01-15 | 22.5 - 25.2 | 23.1 | Out |
Call | NVO Option Call 15-01-2027 120 | 160 | 2027-01-15 | 20.45 - 23.75 | 22.06 | Out |
Call | NVO Option Call 15-01-2027 125 | 100 | 2027-01-15 | 18.6 - 21.75 | 18.9 | Out |
Call | NVO Option Call 15-01-2027 130 | 114 | 2027-01-15 | 16.95 - 20.0 | 16.25 | Out |
Call | NVO Option Call 15-01-2027 135 | 107 | 2027-01-15 | 14.15 - 17.0 | 10.75 | Out |
Call | NVO Option Call 15-01-2027 140 | 168 | 2027-01-15 | 14.0 - 16.55 | 14.45 | Out |
Call | NVO Option Call 15-01-2027 145 | 14 | 2027-01-15 | 12.7 - 15.25 | 12.16 | Out |
Call | NVO Option Call 15-01-2027 150 | 213 | 2027-01-15 | 11.55 - 14.0 | 12.6 | Out |
Call | NVO Option Call 15-01-2027 155 | 18 | 2027-01-15 | 10.55 - 12.8 | 9.6 | Out |
Call | NVO Option Call 15-01-2027 160 | 4 | 2027-01-15 | 9.6 - 11.7 | 8.55 | Out |
Call | NVO Option Call 15-01-2027 165 | 5 | 2027-01-15 | 8.75 - 10.75 | 7.46 | Out |
Call | NVO Option Call 15-01-2027 170 | 150 | 2027-01-15 | 8.0 - 9.85 | 6.45 | Out |
Call | NVO Option Call 15-01-2027 175 | 16 | 2027-01-15 | 7.25 - 9.05 | 7.3 | Out |
Call | NVO Option Call 15-01-2027 180 | 9 | 2027-01-15 | 6.65 - 8.3 | 6.9 | Out |
Call | NVO Option Call 15-01-2027 190 | 5 | 2027-01-15 | 5.55 - 7.05 | 3.74 | Out |
Call | NVO Option Call 15-01-2027 195 | 17 | 2027-01-15 | 5.15 - 6.5 | 5.9 | Out |
Call | NVO Option Call 15-01-2027 200 | 596 | 2027-01-15 | 4.9 - 6.0 | 5.4 | Out |
Put | NVO Option Put 15-01-2027 55 | 11 | 2027-01-15 | 0.5 - 5.0 | 1.55 | Out |
Put | NVO Option Put 15-01-2027 60 | 7 | 2027-01-15 | 1.44 - 2.27 | 2.13 | Out |
Put | NVO Option Put 15-01-2027 65 | 19 | 2027-01-15 | 0.0 - 2.95 | 2.7 | Out |
Put | NVO Option Put 15-01-2027 70 | 74 | 2027-01-15 | 2.91 - 3.8 | 3.5 | Out |
Put | NVO Option Put 15-01-2027 75 | 18 | 2027-01-15 | 3.8 - 4.75 | 4.35 | Out |
Put | NVO Option Put 15-01-2027 80 | 75 | 2027-01-15 | 5.15 - 5.95 | 5.75 | Out |
Put | NVO Option Put 15-01-2027 85 | 68 | 2027-01-15 | 6.5 - 7.35 | 7.01 | Out |
Put | NVO Option Put 15-01-2027 90 | 106 | 2027-01-15 | 7.95 - 8.9 | 8.71 | Out |
Put | NVO Option Put 15-01-2027 95 | 10 | 2027-01-15 | 9.7 - 10.7 | 10.91 | Out |
Put | NVO Option Put 15-01-2027 100 | 51 | 2027-01-15 | 11.6 - 12.7 | 12.0 | Out |
Put | NVO Option Put 15-01-2027 105 | 20 | 2027-01-15 | 13.65 - 14.9 | 14.8 | Out |
Put | NVO Option Put 15-01-2027 110 | 790 | 2027-01-15 | 15.9 - 17.35 | 16.71 | Out |
Put | NVO Option Put 15-01-2027 115 | 194 | 2027-01-15 | 18.6 - 19.9 | 19.16 | In |
Put | NVO Option Put 15-01-2027 120 | 182 | 2027-01-15 | 21.35 - 22.75 | 22.78 | In |
Put | NVO Option Put 15-01-2027 125 | 152 | 2027-01-15 | 25.35 - 26.5 | 26.83 | In |
Put | NVO Option Put 15-01-2027 130 | 36 | 2027-01-15 | 26.35 - 27.45 | 21.7 | In |
Put | NVO Option Put 15-01-2027 135 | 54 | 2027-01-15 | 29.35 - 30.7 | 27.05 | In |
Put | NVO Option Put 15-01-2027 140 | 11 | 2027-01-15 | 34.1 - 36.8 | 35.38 | In |
Put | NVO Option Put 15-01-2027 150 | 12 | 2027-01-15 | 40.1 - 41.5 | 34.45 | In |
Put | NVO Option Put 15-01-2027 155 | 20 | 2027-01-15 | 46.1 - 48.25 | 48.97 | In |
Put | NVO Option Put 15-01-2027 160 | 22 | 2027-01-15 | 50.25 - 52.45 | 53.42 | In |
Put | NVO Option Put 15-01-2027 175 | 6 | 2027-01-15 | 56.0 - 59.9 | 47.82 | In |
Put | NVO Option Put 15-01-2027 180 | 6 | 2027-01-15 | 60.5 - 65.5 | 51.62 | In |
Put | NVO Option Put 15-01-2027 200 | 0 | 2027-01-15 | 86.55 - 90.25 | 93.05 | In |
Novo Nordisk Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Novo Nordisk Market Cap Over Time
Market Cap |
| Timeline |
Novo Total Stockholder Equity
Total Stockholder Equity |
|
Novo Nordisk Corporate Directors
| Kasim Kutay | Director | Profile | |
| Sylvie Gregoire | Independent Director | Profile | |
| Mette Jensen | Director, Employee Representative | Profile | |
| Thomas Rantzau | Director, Employee Representative | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novo Nordisk AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novo Nordisk. If investors know Novo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novo Nordisk listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.224 | Dividend Share 9.9 | Earnings Share 2.99 | Revenue Per Share 60.698 | Quarterly Revenue Growth 0.214 |
The market value of Novo Nordisk AS is measured differently than its book value, which is the value of Novo that is recorded on the company's balance sheet. Investors also form their own opinion of Novo Nordisk's value that differs from its market value or its book value, called intrinsic value, which is Novo Nordisk's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novo Nordisk's market value can be influenced by many factors that don't directly affect Novo Nordisk's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novo Nordisk's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novo Nordisk is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novo Nordisk's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.